AI 4 IMMUNO-ONCOLOGY : ADVANCING CANCER CARE THROUGH AI

AI4Immuno-Oncology: Advancing Cancer Care Through AI

Co-organized by Future4care and the Paris Saclay Cancer Cluster

From data to patient outcomes: What if AI could reshape the entire value chain of immuno-oncology?

AI is no longer just optimizing algorithms—it’s fundamentally redefining how we understand disease, design smarter immunotherapies, and personalize treatment at scale.

From uncovering new biological insights to engineering targeted therapies, predicting patient response, and enabling in silico trials, the convergence of AI and immuno-oncology is ushering in a new era of precision, speed, and impact in cancer care.

What to Expect

• Real-world use cases across the R&D and clinical spectrum

• Insights from leading voices in science, biotech, and AI-driven innovation

• A shared vision of the future of immuno-oncology innovation

Agenda Highlights

• Opening Keynote — AI & Immuno-Oncology: Major Applications & Upcoming Revolutions Confirmed speaker: Pr. Philippe Moingeon

• Panel 1 — From Disease Models to Targets

Confirmed speakers: Sanofi, Cure51

• Panel 2 — Designing the Next Generation of Therapies

Confirmed speakers: Servier, MAbSilico

• Inspiring Keynote — To be revealed… stay tuned!

• Panel 3 — Data-Driven Precision Medicine

Confirmed speakers: Gustave Roussy Institute, GMT Science

Welcome coffee from 8:45 AM | Networking lunch at 12:30 PM

Spots are limited – register now to secure your seat!